| Name | Title | Contact Details |
|---|
Your Single Source for all IT & Cybersecurity Solutions NuView Advisors is a group of vCIO/vCTO/vCISO and IT professionals with decades working with organizations of all sizes to standardize IT and Cybersecurity service delivery to the highest standards. Working with NuView is a force multiplier for IT and Cybersecurity departments to focus on higher value strategic activities, streamlining services across existing organizations and helping startups quickly build their IT services for security and scale.
Designers. Communicators. Team builders. We are Studio Tom, Dick & Harry: the creative internal communication specialists.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.